Non-chaperone proteins can inhibit aggregation and cytotoxicity of Alzheimer amyloid ß peptide

Journal of Biological Chemistry

Volumn 289, Issue 40, 2014, Pages 27766-27775

  Luo, Jinghui ^a   Wärmländer, Sebastian K T S ^b   Gräslund, Astrid ^b   Abrahams, Jan Pieter ^a  

^a LEIDEN UNIVERSITY   (Netherlands)

^b STOCKHOLM UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ENZYMES; GLYCOPROTEINS; NEURODEGENERATIVE DISEASES;

AGGREGATION PROCESS; ALPHA-LACTALBUMIN; ALZHEIMER AMYLOID; ALZHEIMER DISEASE; AMYLOID FORMATION; BROAD SPECTRUM; CHAPERONE ACTIVITY; PYRUVATE KINASE;

PEPTIDES;

ALBUMIN; ALPHA LACTALBUMIN; AMYLOID BETA PROTEIN[1-40]; BETA LACTOGLOBULIN; CATALASE; LYSOZYME; NON CHAPERONE PROTEIN; PROTEIN; PYRUVATE KINASE; UNCLASSIFIED DRUG; AMYLOID BETA PROTEIN; CHAPERONE; PROTEIN AGGREGATE;

ARTICLE; CELL VIABILITY; CIRCULAR DICHROISM; CONTROLLED STUDY; CYTOTOXICITY; FLUORESCENCE; HUMAN; NEUROBLASTOMA CELL; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PROTEIN AGGREGATION; PROTEIN BINDING; PROTEIN STABILITY; STOICHIOMETRY; ALZHEIMER DISEASE; CHEMISTRY; GENETICS; METABOLISM; PROTEINOSIS; TOXICITY;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; HUMANS; MOLECULAR CHAPERONES; PROTEIN AGGREGATES; PROTEIN AGGREGATION, PATHOLOGICAL;

EID: 84907482249     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M114.574947     Document Type: Article

References (46)

1. Glenner, G. G., and Wong, C. W. (1984) Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem. Biophys. Res. Commun. 120, 885-890
2. Benilova, I., Karran, E., and De Strooper, B. (2012) The toxic Aß oligomer and Alzheimer's disease: an emperor in need of clothes. Nat Neurosci. 15, 349-357
3. Cohen, S. I., Linse, S., Luheshi, L. M., Hellstrand, E., White, D.A., Rajah, L., Otzen, D. E., Vendruscolo, M., Dobson, C. M., and Knowles, T. P. (2013) Proliferation of amyloid-ß42 aggregates occurs through a secondary nucleation mechanism. Proc. Natl. Acad. Sci. U.S.A. 110, 9758 -9763
4. Necula, M., Kayed, R., Milton, S., and Glabe, C. G. (2007) Small molecule inhibitors of aggregation indicate that amyloid ß oligomerization and fibrillization pathways are independent and distinct. J. Biol. Chem. 282, 10311-10324
5. Sievers, S. A., Karanicolas, J., Chang, H. W., Zhao, A., Jiang, L., Zirafi, O., Stevens, J. T., Münch, J., Baker, D., and Eisenberg, D. (2011) Structurebased design of non-natural amino acid inhibitors of amyloid fibril formation. Nature 475, 96 -100
6. Luo, J., Otero, J. M., Yu, C.-H., Wärmländer, S. K., Gräslund, A., Overhand, M., and Abrahams, J. P. (2013) Inhibiting and reversing amyloid-ß peptide (1-40) fibril formation with gramicidin S and engineered analogues. Chemistry 19, 17338-17348
7. Luo, J., and Abrahams, J. P. (2014) Cyclic peptides as inhibitors of amyloid fibrillation. Chemistry 20, 2410-2419
8. Hoyer, W., Grönwall, C., Jonsson, A., Ståhl, S., and Härd, T. (2008) Stabilization of a ß-hairpin in monomeric Alzheimer's amyloid-ß peptide inhibits amyloid formation. Proc. Natl. Acad. Sci. U.S.A. 105, 5099-5104
9. Sandberg, A., Luheshi, L. M., Söllvander, S., Pereira de Barros, T., Macao, B., Knowles, T. P., Biverstål, H., Lendel, C., Ekholm-Petterson, F., Dubno- vitsky, A., Lannfelt, L., Dobson, C. M., and Härd, T. (2010) Stabilization of neurotoxic Alzheimer amyloid-ß oligomers by protein engineering. Proc. Natl. Acad. Sci. U.S.A. 107, 15595-155600
10. Santhoshkumar, P., and Sharma, K. K. (2004) Inhibition of amyloid fibrillogenesis and toxicity by a peptide chaperone. Mol. Cell Biochem. 267, 147-155
11. Narayan, P., Orte, A., Clarke, R. W., Bolognesi, B., Hook, S., Ganzinger, K. A., Meehan, S., Wilson, M. R., Dobson, C. M., and Klenerman, D. (2012) The extracellular chaperone clusterin sequesters oligomeric forms of the amyloid-ß(l-40) peptide.Nat. Struct. Mol. Biol. 19, 79-83
12. Wilhelmus, M. M., Boelens, W. C., Otte-Höller, I., Kamps, B., Kusters, B., Maat-Schieman, M. L., de Waal, R. M., and Verbeek, M. M. (2006) Small heat shock protein HspB8: its distribution in Alzheimer's disease brains and its inhibition of amyloid-ß protein aggregation and cerebrovascular amyloid-ß toxicity. Acta Neuropathol. 111, 139-149
13. Evans, C. G., Wisén, S., and Gestwicki,J. E. (2006) Heat shock proteins 70 and 90 inhibit early stages of amyloid ß-(l-42) aggregation in vitro. J. Biol. Chem. 281, 33182-33191
14. Olzscha, H., Schermann, S. M., Woerner, A. C., Pinkert, S., Hecht, M. H., Tartaglia, G. G., Vendruscolo, M., Hayer-Hartl, M., Hartl, F.U., and Vabulas, R. M. (2011) Amyloid-like aggregates sequester numerous metastable proteins with essential cellular functions. Cell 144, 67-78
15. Ferreon, A. C., Ferreon, J. C., Wright, P. E., and Deniz, A. A. (2013) Modulation of allostery by protein intrinsic disorder. Nature 498, 390 -394
16. Milton, N. G. (1999) Amyloid-ß binds catalase with high affinity and inhibits hydrogen peroxide breakdown. Biochem. J. 344, 293-296
17. Casley, C. S., Canevari, L., Land, J. M., Clark, J. B., and Sharpe, M. A. (2002) ß-Amyloid inhibits integrated mitochondrial respiration and key enzyme activities. J. Neurochem. 80, 91-100
18. Luo, J., Wärmländer, S. K. T. S., Gräslund, A., and Abrahams, J. P. (2013) Human lysozyme inhibits the in vitro aggregation of Aß peptides, which in vivo are associated with Alzheimer's disease. Chem. Commun. (Camb)49, 6507-6509
19. Willander, H., Presto, J., Askarieh, G., Biverstål, H., Frohm, B., Knight, S. D., Johansson, J., and Linse, S. (2012) BRICHOS domains efficiently delay fibrillation of amyloid ß-peptide.J Biol. Chem. 287, 31608-31617
20. Stanyon, H. F., and Viles, J. H. (2012) Human serum albumin can regulate amyloid-ß peptide fiber growth in the brain interstitium: implications for Alzheimer disease. J. Biol. Chem. 287, 28163-28168
21. Luo, J., Yu, C.-H., Yu, H., Borstnar, R., Kamerlin, S. C., Gräslund, A., Abrahams, J. P., and Wärmländer, S. K. (2013) Cellular polyamines promote amyloid-ß (aß) peptide fibrillation and modulate the aggregation pathways. ACS Chem. Neurosci. 4, 454-462
22. Luo, J., Mohammed, I., Wärmländer, S. K., Hiruma, Y., Gräslund, A., and Abrahams, J. P. (2014) Endogenous polyamines reduce the toxicity of soluble A ß peptide aggregates associated with Alzheimer's disease. Biomacromolecules 15, 1985-1991
23. Maurer-Stroh, S., Debulpaep, M., Kuemmerer, N., Lopez de la Paz, M., Martins, I. C., Reumers, J., Morris, K. L., Copland, A., Serpeli, L., Serrano, L., Schymkowitz, J. W., and Rousseau, F. (2010) Exploring the sequence determinants of amyloid structure using position-specific scoring matrices. Nat. Methods 7, 237-242
24. Pettersen, E. F., Goddard, T. D., Huang, C. C., Couch, G. S., Greenblatt, D. M., Meng, E. C., and Ferrin, T. E. (2004) UCSF Chimera. A visualization system for exploratory research and analysis. J. Comput. Chem. 25, 1605-1612
25. Sluzky, V., Tamada, J. A., Klibanov, A.M., and Langer, R. (1991) Kinetics of insulin aggregation in aqueous solutions upon agitation in the presence of hydrophobic surfaces. Proc. Natl. Acad. Sci. U.S.A. 88, 9377-9381
26. Campioni, S., Carret, G., Jordens, S., Nicoud, L., Mezzenga, R., and Riek, R. (2014) The presence of an air-water interface affects formation and elongation of a-synuclein fibrils. J. Am. Chem. Soc. 136, 2866 -2875
27. Bolognesi, B., Kumita, J. R., Barros, T. P., Esbjorner, E. K., Luheshi, L. M., Crowther, D. C., Wilson, M. R., Dobson, C. M., Favrin, G., and Yerbury, J. J. (2010) ANS binding reveals common features of cytotoxic amyloid species. ACS Chem. Biol. 5, 735-740
28. Glabe, C. G. (2008) Structural classification of toxic amyloid oligomers. J. Biol. Chem. 283, 29639-29643
29. Saio, T., Guan, X., Rossi, P., Economou, A., and Kalodimos, C. G. (2014) Structural basis for protein antiaggregation activity of the trigger factor chaperone. Science 344, 1250494-1250511
30. Karagöz, G. E., Duarte, A. M., Akoury, E., Ippel, H., Biernat, J., Morán Luengo, T., Radii, M., Didenko, T., Nordhues, B. A., Veprintsev, D. B., Dickey, C. A., Mandelkow, E., Zweckstetter, M., Boelens, R., Madl, T., and Rüdiger, S. G. (2014) Hsp90-Tau complex reveals molecular basis for specificity in chaperone action. Cell 156, 963-974
31. Van Dael, H., Tieghem, E., Haezebrouck, P., and Van Cauwelaert, F. (1992) Conformational aspects of the Cu2+ binding to α-lactalbumin: characterization and stability of the Cu-bound state. Biophys. Chem. 42, 235-242
32. Divsalar, A., Damavandi, S. E., Saboury, A. A., Seyedarabi, A., and Moosavi-Movahedi, A. A. (2012) Calorimetric and spectroscopic investigations of ß-lactoglobulin upon interaction with copper ion. J. Dairy Res. 79, 209-215
33. Laganowsky, A., Liu, C., Sawaya, M. R., Whitelegge, J. P., Park, J., Zhao, M., Pensalfini, A., Soriaga, A. B., Landau, M., Teng, P. K., Casci o, D., Glabe, C., and Eisenberg, D. (2012) Atomic view of a toxic amyloid small oligomer. Science 335, 1228-1231
34. Bigl, M., Brückner, M. K., Arendt, T., Bigi, V., and Eschrich, K. (1999) Activities of key glycolytic enzymes in the brains of patients with Alzheimer's disease. J. Neural Transm. 106, 499-511
35. Yamamoto, K., Shimada, H., Koh, H., Ataka, S., and Mild, T. (2014) Serum levels of albumin-amyloid ß complexes are decreased in Alzheimer's disease. Geriatr. Gerontol. Int. 14, 716-723
36. Kim, Y. E., Hipp, M. S., Bracher, A., Hayer-Hartl, M., and Hartl, F. U. (2013) Molecular chaperone functions in protein folding and proteostasis. Annu. Rev. Biochem. 82, 323-355
37. Wyatt, A. R., Yerbury, J. J., Ecroyd, H., and Wilson, M. R. (2013) Extracellular chaperones and proteostasis. Annu. Rev. Biochem. 82, 295-322
38. Yerbury, J. J., Poon, S., Meehan, S., Thompson, B., Kumita, J. R., Dobson, C. M., and Wilson, M. R. (2007) The extracellular chaperone clusterin influences amyloid formation and toxicity by interacting with prefibrillar structures. FASEB J. 21, 2312-2322
39. Yerbury, J. J., Kumita, J. R., Meehan, S., Dobson, C. M., and Wilson, M. R. (2009) α2-Macroglobulin and haptoglobin suppress amyloid formation by interacting with prefibrillar protein species. J Biol. Chem. 284, 4246-4254
40. Fonte, V., Kapulkin, W. J., Kapulkin, V., Taft, A., Fluet, A., Friedman, D., and Link, C. D. (2002) Interaction of intracellular ß amyloid peptide with chaperone proteins. Proc. Natl. Acad. Sci. 99, 9439 -9444
41. Arimon, M., Grimminger, V., Sanz, F., and Lashuel, H. A. (2008) Hsp104 targets multiple intermediates on the amyloid pathway and suppresses the seeding capacity of Aß fibrils and protofibrils.J. Mol. Biol. 384, 1157-1173
42. Milojevic, J., and Melacini, G. (2011) Stoichiometry and affinity of the human serum albumin-Alzheimer's Aß peptide interactions. Biophys. J. 100, 183-192
43. Milojevic, J., Raditsis, A., and Melacini, G. (2009) Human serum albumin inhibits Aß fibrillization through a "monomer-competitor" mechanism. Biophys. J. 97, 2585-2594.
44. Ono, K., Takahashi, R., Ikeda, T., and Yamada, M. (2012) Cross-seeding effects of amyloid ß-protein and α-synuclein.J. Neurochem. 122, 883- 890
45. Clinton, L. K., Blurton-Jones, M., Myczek, K., Trojanowski, J. Q., and LaFerla, F. M. (2010) Synergistic Interactions between Aß, Tau, and α-synuclein: acceleration of neuropathology and cognitive decline.J. Neurosci. 30, 7281-7289
46. Mandal, P. K., Pettegrew, J. W., Masliah, E., Hamilton, R. L., and Mandal, R. (2006) Interaction between Aß peptide and α synuclein: molecular mechanisms in overlapping pathology of Alzheimer's and Parkinson's in dementia with Lewy body disease. Neurochem. Res. 31, 1153-1162